{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:41:43Z","timestamp":1791862903675,"version":"4.3.4"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Manipal Academy of Higher Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbcan.2020.188475","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T15:46:34Z","timestamp":1605109594000},"page":"188475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits"],"prefix":"10.1016","volume":"1875","author":[{"given":"Sudha","family":"Warrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyukta","family":"Bhansali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Varier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0015","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"18","key":"10.1016\/j.bbcan.2020.188475_bb0020","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bbcan.2020.188475_bb0025","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","article-title":"Identification of bronchioalveolar stem cells in normal lung and lung cancer","volume":"121","author":"Kim","year":"2005","journal-title":"Cell"},{"issue":"1 Suppl 1","key":"10.1016\/j.bbcan.2020.188475_bb0035","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MD.0000000000004764","article-title":"Cancer stem cells: understanding tumor hierarchy and heterogeneity","volume":"95","author":"Rich","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbcan.2018.10.004","article-title":"Role of tumor-derived exosomes in cancer metastasis","volume":"1871","author":"Wee","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2020.188475_bb0045","article-title":"A preliminary study of the relationship between breast cancer metastasis and loss of heterozygosity by using exome sequencing","volume":"4","author":"Hongsheng Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2020.188475_bb0050","series-title":"Cancer Registration & Surveillance Modules","author":"Modules","year":"2020"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5483\/BMBRep.2017.50.6.039","article-title":"Cancer stem cell surface markers on normal stem cells","volume":"50","author":"Kim","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbcan.2020.188475_bb0060","doi-asserted-by":"crossref","first-page":"43008","DOI":"10.1038\/srep43008","article-title":"Prognostic value of cancer stem cell markers in head and neck squamous cell carcinoma: a meta-analysis","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2007.11.103","article-title":"CD200: a putative therapeutic target in cancer","volume":"366","author":"Moreaux","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.bbcan.2020.188475_bb0070","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.18632\/oncotarget.2269","article-title":"CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma","volume":"5","author":"Murillo-Sauca","year":"2014","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.bbcan.2020.188475_bb0075","doi-asserted-by":"crossref","first-page":"31943","DOI":"10.18632\/oncotarget.8218","article-title":"Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression","volume":"7","author":"Ortiz-Sanchez","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62205-6","article-title":"Renal carcinoma CD105\u2212\/CD44\u2212 cells display stem-like properties in vitro and form aggressive tumors in vivo","volume":"10","author":"Fiedorowicz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2020.188475_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fonc.2017.00080","article-title":"Targeting lung Cancer stem cells: research and clinical impacts","volume":"7","author":"Zakaria","year":"2017","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00432-019-02907-1","article-title":"Elevated integrin alpha6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics","volume":"145","author":"Shen","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"33","key":"10.1016\/j.bbcan.2020.188475_bb0095","doi-asserted-by":"crossref","first-page":"23306","DOI":"10.18632\/oncotarget.24623","article-title":"Cancer stem cells of hepatocellular carcinoma","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2020.188475_bb0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.21037\/sci.2017.11.03","article-title":"Breast cancer stem cells-from origins to targeted therapy","volume":"4","author":"Sin","year":"2017","journal-title":"Stem Cell Invest."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1634\/stemcells.2005-0282","article-title":"Characterization of a side population of cancer cells from human gastrointestinal system","volume":"24","author":"Haraguchi","year":"2006","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0110","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2014.2529","article-title":"Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer","volume":"45","author":"Castillo","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2020.188475_bb0115","series-title":"Basic Principles and Practice in Surgery","article-title":"Stem cell markers in colon cancer","author":"Pop","year":"2019"},{"issue":"1A","key":"10.1016\/j.bbcan.2020.188475_bb0120","first-page":"48","article-title":"Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance","volume":"22","author":"Klemba","year":"2018","journal-title":"Contemp. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188475_bb0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2007.10.067","article-title":"Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells","volume":"364","author":"Kawasaki","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40169-018-0198-1","article-title":"The role of CD133 in cancer: a concise review","volume":"7","author":"Glumac","year":"2018","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance","volume":"68","author":"Matsui","year":"2008","journal-title":"Cancer Res."},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2020.188475_bb0140","first-page":"2S16","article-title":"Detection of cancer stem cell markers in sarcomas","volume":"25","author":"Veselska","year":"2012","journal-title":"Klin. Onkol."},{"key":"10.1016\/j.bbcan.2020.188475_bb0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fonc.2018.00475","article-title":"Soft tissue sarcoma Cancer stem cells: an overview","volume":"8","author":"Genadry","year":"2018","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2020.188475_bb0150","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1158\/0008-5472.CAN-10-1495","article-title":"Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188475_bb0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/modpathol.2009.113","article-title":"Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma","volume":"22","author":"Tsiatis","year":"2009","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0160","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7150\/jca.8865","article-title":"Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles","volume":"5","author":"Yan","year":"2014","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0165","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/stem.452","article-title":"Synovial sarcoma is a stem cell malignancy","volume":"28","author":"Naka","year":"2010","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0170","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2012.940","article-title":"Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines","volume":"4","author":"Liu","year":"2012","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0175","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2020.188475_bb0180","first-page":"10(9)","author":"Arora","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.bbcan.2020.188475_bb0185","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1182\/blood-2008-11-189688","article-title":"Circulating clonotypic B cells in classic Hodgkin lymphoma","volume":"113","author":"Jones","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41375-018-0180-3","article-title":"Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML","volume":"33","author":"Haubner","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2020.188475_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exphem.2017.04.003","article-title":"Expression of CD25 on leukemic stem cells in BCR-ABL1(+) CML: potential diagnostic value and functional implications","volume":"51","author":"Sadovnik","year":"2017","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0574-7","article-title":"Understanding of leukemic stem cells and their clinical implications","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0161-1","article-title":"Targeting Wnt pathway in mantle cell lymphoma-initiating cells","volume":"8","author":"Mathur","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2020.188475_bb0210","first-page":"1","article-title":"CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy","author":"Kinstrie","year":"2020","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.bbcan.2020.188475_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cgt.2014.42","article-title":"Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition","volume":"21","author":"Warrier","year":"2014","journal-title":"Cancer Gene Ther."},{"issue":"8","key":"10.1016\/j.bbcan.2020.188475_bb0220","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2020.188475_bb0225","first-page":"11(1)","article-title":"Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma","author":"Bhuvanalakshmi","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188475_bb0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.febslet.2015.01.009","article-title":"MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal","volume":"589","author":"Liu","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2020.188475_bb0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2017.00124","article-title":"Breast Cancer stem-like cells are inhibited by Diosgenin, a steroidal Saponin, by the attenuation of the Wnt beta-catenin signaling via the Wnt antagonist secreted frizzled related Protein-4","volume":"8","author":"Bhuvanalakshmi","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0240","article-title":"Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties","volume":"10","author":"Bhuvanalakshmi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2020.188475_bb0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biocel.2019.02.001","article-title":"Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: development of 3D primed therapeutic MSCs","volume":"110","author":"Mandal","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","article-title":"The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?","volume":"16","author":"Plaks","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2020.188475_bb0255","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3332\/ecancer.2017.721","article-title":"Dual role of inflammatory mediators in cancer","volume":"11","author":"Shrihari","year":"2017","journal-title":"Ecancermedicalscience"},{"issue":"19","key":"10.1016\/j.bbcan.2020.188475_bb0260","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","article-title":"Regulation of cancer stem cells by cytokine networks: attacking cancer\u2019s inflammatory roots","volume":"17","author":"Korkaya","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0265","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00109-013-1095-0","article-title":"Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products","volume":"92","author":"Manu","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188475_bb0270","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","article-title":"Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0360-3016(01)01630-3","article-title":"Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer","volume":"51","author":"Brizel","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbcan.2020.188475_bb0280","first-page":"819","article-title":"The origin of cancer stem cells","volume":"4","author":"Bu","year":"2012","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"10.1016\/j.bbcan.2020.188475_bb0285","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fimmu.2020.00526","article-title":"The interactions between Cancer stem cells and the innate interferon signaling pathway","volume":"11","author":"Martin-Hijano","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2789","article-title":"ABC transporters in cancer: more than just drug efflux pumps","volume":"10","author":"Fletcher","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0295","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0300","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0305","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-009-0612-x","article-title":"Targeting breast stem cells with the cancer preventive compounds curcumin and piperine","volume":"122","author":"Kakarala","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"14","key":"10.1016\/j.bbcan.2020.188475_bb0310","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4161\/cc.9.14.12371","article-title":"Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs","volume":"9","author":"Cioce","year":"2010","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2006.08.016","article-title":"Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients","volume":"73","author":"Wickstr\u00f6m","year":"2007","journal-title":"Biochemical pharmacology"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0320","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/bjc.2014.71","article-title":"Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma","volume":"110","author":"Saroufim","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0325","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15283\/ijsc.2014.7.2.118","article-title":"Comparison of mesenchymal stem cell markers in multiple human adult stem cells","volume":"7","author":"Maleki","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.bbcan.2020.188475_bb0330","doi-asserted-by":"crossref","first-page":"2087204","DOI":"10.1155\/2016\/2087204","article-title":"The importance of CD44 as a stem cell biomarker and therapeutic target in Cancer","volume":"2016","author":"Thapa","year":"2016","journal-title":"Stem Cells Int."},{"issue":"1A","key":"10.1016\/j.bbcan.2020.188475_bb0335","first-page":"A52","article-title":"Immunotargeting of cancer stem cells","volume":"19","author":"Kwiatkowska-Borowczyk","year":"2015","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"10.1016\/j.bbcan.2020.188475_bb0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2020.188475_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/sci.2018.02.02","article-title":"Targeting Notch signalling pathway of cancer stem cells","volume":"5","author":"Venkatesh","year":"2018","journal-title":"Stem Cell Investig."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-09-1681","article-title":"Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor","volume":"70","author":"Harrison","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188475_bb0355","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1349-7006.2011.01943.x","article-title":"Essential role of the hedgehog signaling pathway in human glioma-initiating cells","volume":"102","author":"Takezaki","year":"2011","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188475_bb0360","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.2174\/1381612822666160112130157","article-title":"One hundred faces of Cyclopamine","volume":"22","author":"Iovine","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188475_bb0365","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1634\/stemcells.2008-0459","article-title":"Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas","volume":"26","author":"Xu","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3727\/096504013X13786659070154","article-title":"Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells","volume":"21","author":"Warrier","year":"2013","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7150\/ijbs.23756","article-title":"Frizzled7 promotes epithelial-to-mesenchymal transition and Stemness via activating canonical Wnt\/beta-catenin pathway in gastric Cancer","volume":"14","author":"Li","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"5\u2013S","key":"10.1016\/j.bbcan.2020.188475_bb0380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.22270\/jddt.v8i5-s.1921","article-title":"Anti-CSC combination therapy using Wnt signaling-targeted drug","volume":"8","author":"Dhandapani","year":"2018","journal-title":"J. Drug Deliv. Therap."},{"key":"10.1016\/j.bbcan.2020.188475_bb0385","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2020.01.008","article-title":"DNA damage response and resistance of cancer stem cells","volume":"474","author":"Abad","year":"2020","journal-title":"Cancer Lett."},{"issue":"7120","key":"10.1016\/j.bbcan.2020.188475_bb0390","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0395","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2013.136","article-title":"Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells","volume":"21","author":"Venere","year":"2014","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molonc.2014.08.003","article-title":"Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase","volume":"9","author":"Carruthers","year":"2015","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188475_bb0405","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/cdd.2011.170","article-title":"Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy","volume":"19","author":"Bartucci","year":"2012","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0410","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/MCB.24.2.730-740.2004","article-title":"Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases","volume":"24","author":"Majewski","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.3101","article-title":"Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells","volume":"38","author":"Visweswaran","year":"2020","journal-title":"Stem Cells"},{"issue":"7390","key":"10.1016\/j.bbcan.2020.188475_bb0420","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.bbcan.2020.188475_bb0425","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0430","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/bcr2240","article-title":"Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity","volume":"11","author":"Kourtidis","year":"2009","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188475_bb0435","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0039.2008.01106.x","article-title":"Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands","volume":"72","author":"Campoli","year":"2008","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188475_bb0440","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0445","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/imt-2019-0108","article-title":"5 years of clinical DC-CIK\/NK cells immunotherapy for acute myeloid leukemia - a summary","volume":"12","author":"Zhang","year":"2020","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188475_bb0450","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/1440-1681.12732","article-title":"Increased PD-L1 expression in breast and colon cancer stem cells","volume":"44","author":"Wu","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0455","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/19420862.2015.1136043","article-title":"Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor","volume":"8","author":"Deng","year":"2016","journal-title":"MAbs"},{"issue":"27","key":"10.1016\/j.bbcan.2020.188475_bb0460","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1200\/JCO.2008.16.6462","article-title":"Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer","volume":"26","author":"Barve","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0465","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological characterization of cancer stem cells isolated from glioblastoma patients","volume":"16","author":"Di Tomaso","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bbcan.2020.188475_bb0470","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-09-2687","article-title":"Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells","volume":"69","author":"Brown","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188475_bb0475","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4419-7037-4_8","article-title":"MicroRNA regulation of embryonic stem cell self-renewal and differentiation","volume":"695","author":"Melton","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0480","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cas.12656","article-title":"Micro RNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway","volume":"106","author":"Kang","year":"2015","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188475_bb0485","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4161\/cc.9.6.10987","article-title":"microRNA-34a is tumor suppressive in brain tumors and glioma stem cells","volume":"9","author":"Guessous","year":"2010","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0490","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/14728222.2014.988708","article-title":"The molecular mechanisms and therapeutic potential of microRNA-7 in cancer","volume":"19","author":"Gu","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"27","key":"10.1016\/j.bbcan.2020.188475_bb0495","doi-asserted-by":"crossref","first-page":"24017","DOI":"10.18632\/oncotarget.4447","article-title":"MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4\/PI3K\/Akt\/p21 pathway","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bbcan.2020.188475_bb0500","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/stem.1795","article-title":"MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway","volume":"32","author":"Zhang","year":"2014","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0505","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/CBM-170642","article-title":"Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation","volume":"21","author":"Zuo","year":"2018","journal-title":"Cancer Biomark"},{"issue":"19","key":"10.1016\/j.bbcan.2020.188475_bb0510","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"Si","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2020.188475_bb0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","article-title":"S GR, Levi E et al, miR-21 and miR-145 cooperation in regulation of colon cancer stem cells","volume":"14","author":"Yu","year":"2015","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2020.188475_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050165","article-title":"Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0525","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11033-014-3820-3","article-title":"MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG","volume":"42","author":"Shang","year":"2015","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0530","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12957-016-1028-9","article-title":"Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line","volume":"14","author":"Jiang","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188475_bb0535","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1007\/s13277-014-2158-8","article-title":"MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells","volume":"35","author":"Hu","year":"2014","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188475_bb0540","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jcmm.12358","article-title":"MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways","volume":"18","author":"Cui","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188475_bb0545","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3892\/ijo.2017.3857","article-title":"MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells","volume":"50","author":"Zhou","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"34","key":"10.1016\/j.bbcan.2020.188475_bb0550","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.3748\/wjg.v25.i34.5026","article-title":"Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors","volume":"25","author":"Galamb","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188475_bb0555","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40169-019-0253-6","article-title":"Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment","volume":"8","author":"Skaga","year":"2019","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188475_bb0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2020.188475_bb0565","first-page":"1","article-title":"The translational status of cancer liquid biopsies","author":"Bratulic","year":"2019","journal-title":"Regen. Eng. Transl. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:36:20Z","timestamp":1759638980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X20301943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0304419X20301943"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188475","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188475"}}